Israel-Georgian Medical Research Clinic Healthycore

Tbilisi 0159

2 studies enrolling now · 6 studies all time

What they study most

1st Line NSCLC, Advanced Non-Small Cell Lung Cancer, Advanced Solid Tumor, Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, Breast Cancer, Carcinoma, Hepatocellular, Melanoma, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Untreated Advanced NSCLC

Studies at this site

• Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers — Recruiting now
• A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors — Recruiting now
• A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer — Running, not enrolling
• Study With Various Immunotherapy Treatments in Participants With Lung Cancer — Running, not enrolling
• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
• Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7 — Stopped early